Matches in Wikidata for { <http://www.wikidata.org/entity/Q64187948> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q64187948 description "clinical trial" @default.
- Q64187948 description "ensayu clínicu" @default.
- Q64187948 description "klinisch onderzoek" @default.
- Q64187948 description "клінічне випробування" @default.
- Q64187948 name "A Study to Evaluate Safety and Effects of Sotagliflozin Dose 1 and Dose 2 on Glucose Control in Patients With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control" @default.
- Q64187948 type Item @default.
- Q64187948 label "A Study to Evaluate Safety and Effects of Sotagliflozin Dose 1 and Dose 2 on Glucose Control in Patients With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control" @default.
- Q64187948 prefLabel "A Study to Evaluate Safety and Effects of Sotagliflozin Dose 1 and Dose 2 on Glucose Control in Patients With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control" @default.
- Q64187948 P1050 Q64187948-F8B23B3C-9B91-4381-AE8E-9454A4174DAC @default.
- Q64187948 P1132 Q64187948-20F615FC-D3B9-4986-8926-6646D249E963 @default.
- Q64187948 P1476 Q64187948-519E6390-B676-434F-A748-04B5E2343F13 @default.
- Q64187948 P17 Q64187948-04FD5E17-E5FA-418D-AD48-F6501EFE2B7A @default.
- Q64187948 P17 Q64187948-0FC4398A-8C46-4F09-A7BD-6868E6F10B3D @default.
- Q64187948 P17 Q64187948-162C5A37-6991-4A65-9E58-71E248964442 @default.
- Q64187948 P17 Q64187948-3EA38345-7DF3-49A9-9E48-4AB0D3079429 @default.
- Q64187948 P17 Q64187948-483A8460-8963-41A1-B494-092A69C958C1 @default.
- Q64187948 P17 Q64187948-59F58AE8-6988-403D-921D-7F69977B9509 @default.
- Q64187948 P17 Q64187948-68B1D348-6AB9-495F-9D1A-07FF7BAEA915 @default.
- Q64187948 P17 Q64187948-73B57485-17EE-4F36-AE5C-4A74F9482206 @default.
- Q64187948 P17 Q64187948-915D92D7-501A-409E-B903-A0830EDE99E1 @default.
- Q64187948 P17 Q64187948-961747A7-1EBC-49AB-ABE1-75D8541492A5 @default.
- Q64187948 P17 Q64187948-A0A23964-8C17-4FBF-80F9-7833F8D55E0D @default.
- Q64187948 P17 Q64187948-C169F707-EFE5-45F3-8937-10EC90E79C3E @default.
- Q64187948 P17 Q64187948-DE99933A-013B-492B-BED6-166E0BDAF4A4 @default.
- Q64187948 P17 Q64187948-E908941D-ECAB-4602-B979-20E8260DAD6B @default.
- Q64187948 P1813 Q64187948-38F042DA-20D6-460D-9A28-42469F24C42D @default.
- Q64187948 P2899 Q64187948-82072F0A-164C-4304-86F0-4C526666401B @default.
- Q64187948 P3098 Q64187948-D359BC96-85DD-4569-AD84-67A6368FB291 @default.
- Q64187948 P31 Q64187948-E703748D-975C-456C-BA18-AD96C796D828 @default.
- Q64187948 P580 Q64187948-396D1F78-1BF3-45BA-8D39-707B8D3CC077 @default.
- Q64187948 P582 Q64187948-18441793-16FD-4B07-ABEA-7FF28BEC9262 @default.
- Q64187948 P6099 Q64187948-B07F770C-A317-433C-A449-9CC10812AA41 @default.
- Q64187948 P8363 Q64187948-B781FE1F-DD2B-4C66-AB5D-BBC0C76F7585 @default.
- Q64187948 P1050 Q12206 @default.
- Q64187948 P1132 "+276" @default.
- Q64187948 P1476 "A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Severe Renal Impairment Who Have Inadequate Glycemic Control" @default.
- Q64187948 P17 Q155 @default.
- Q64187948 P17 Q183 @default.
- Q64187948 P17 Q212 @default.
- Q64187948 P17 Q218 @default.
- Q64187948 P17 Q258 @default.
- Q64187948 P17 Q28 @default.
- Q64187948 P17 Q29 @default.
- Q64187948 P17 Q30 @default.
- Q64187948 P17 Q36 @default.
- Q64187948 P17 Q38 @default.
- Q64187948 P17 Q414 @default.
- Q64187948 P17 Q739 @default.
- Q64187948 P17 Q801 @default.
- Q64187948 P17 Q96 @default.
- Q64187948 P1813 "SOTA-CKD4" @default.
- Q64187948 P2899 "+18" @default.
- Q64187948 P3098 "NCT03242018" @default.
- Q64187948 P31 Q30612 @default.
- Q64187948 P580 "2017-08-17T00:00:00Z" @default.
- Q64187948 P582 "2019-12-01T00:00:00Z" @default.
- Q64187948 P6099 Q42824827 @default.
- Q64187948 P8363 Q78089383 @default.